H7N9 influenza viruses were first isolated in 2013 and continue to cause human infections.
H7N9 infections represent an ongoing public health threat that has resulted in 1344 cases …

In early 2013, human infections caused by a novel H7N9 avian influenza virus (AIV) were
first reported in China; these infections caused severe disease and death. The virus was …

Human Infection with an Avian-Origin Influenza A (H10N3) Virus | New England Journal of
Medicine Skip to main content The New England Journal of Medicine homepage Advanced …

Due to enzootic infections in poultry and persistent human infections in China, influenza A
(H7N9) virus has remained a public health threat. The Yangtze River Delta region, which is …

The continuous emergence and reemergence of diverse subtypes of influenza A viruses,
which are known as “HxNy” and are mediated through the reassortment of viral genomes …

The neuraminidase (NA) of influenza A and B viruses plays a distinct role in viral replication
and has a highly conserved catalytic site. Numerous sialic (neuraminic) acid analogs that …

Several subtypes of avian influenza viruses (AIVs) are emerging as novel human
pathogens, and the frequency of related infections has increased in recent years. Although …

Mutations in influenza virus neuraminidase (NA) can lead to viral resistance to NA inhibitors
(NAIs). To update global influenza NA mutations and resistance to NAIs, we investigated …

Background Neuraminidase (NA) inhibitors are the recommended antiviral medications for
influenza treatment. However, their therapeutic efficacy can be compromised by NA changes …

Neuraminidase inhibitors (NAIs) are antiviral agents recommended worldwide to treat or
prevent influenza virus infections in humans. Past influenza virus pandemics seeded by …